|
The Biotherapy Development Association e.V (BDA) is an international organisation devoted to education, pre-clinical and clinical research and development of biological therapies for cancer.
The BDA wishes to acknowledge support by an unrestricted grant from Quintiles Transnational towards the development of this website. Quintiles Transnational help improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries.To learn more please visit www.quintiles.com
BDA are working in partnership with the International Society for Biological Therapy of Cancer.
BDA and iSBTc members present at conferences hosted by both organisations
iSBTc Introduction
The goals of iSBTc are directed towards the rapid dissemination of information in appropriate areas to expedite the safe transfer of both basic and applied research to the clinical setting.
iSBTc Objective:
To improve outcomes for cancer patients by advancing the development and application of biological therapy through research.
iSBTc Core Values
1. Interaction – exchange of information and education among basic research and clinicians
2. Innovation – in the development and application of biological therapy; seeking the best research and thinking related to the Society’s purpose and vision
3. Leadership – defining what is new and important
to learn more please visit http://www.isbtc.org
|
"The future of molecular targeted therapy requires a detailed understanding of translational R&D and economies." |
|
